PMID: 9651511Jul 4, 1998Paper

Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis

Brain Research. Brain Research Reviews
R R GainetdinovM G Caron

Abstract

Mice with a genetic deletion of the dopamine transporter (DAT) were used to assess its role in the function of dopamine (DA) neurons. Profound alterations in the homeostasis of the nigrostriatal DA system were induced by the absence of the DAT. Extracellular levels of DA were elevated and clearance of released DA was 300-times slower than in control mice. This was accompanied by a 20-fold decrease in tissue DA levels and a paradoxical doubling of the rate of DA synthesis. A crucial role is indicated for the DAT in maintenance of DA neuron presynaptic function, particularly in the control of storage mechanisms.

References

Dec 29, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·J R Walters, R H Roth
May 1, 1992·Brain Research. Molecular Brain Research·S ShimadaG Uhl
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M J BannonG Kapatos
May 1, 1992·Trends in Pharmacological Sciences·W L Woolverton, K M Johnson
Oct 1, 1985·The Journal of Pharmacy and Pharmacology·E PilebladA Carlsson
Jan 1, 1981·Journal of Neural Transmission·U K RinneV Koskinen
Jan 1, 1994·Pharmacology & Therapeutics·D M Jackson, A Westlind-Danielsson
Jan 1, 1993·Annual Review of Neuroscience·S G Amara, M J Kuhar
Jul 1, 1993·Journal of Neuroscience Methods·J B Justice
Feb 1, 1993·Trends in Pharmacological Sciences·B Giros, M G Caron
Apr 11, 1997·European Journal of Pharmacology·M E ReithN H Chen
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·S R JonesM G Caron

❮ Previous
Next ❯

Citations

Dec 7, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Raul R Gainetdinov
Oct 19, 2010·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Nan-Tsing ChiuYen Kuang Yang
Sep 10, 2004·Current Psychiatry Reports·Thomas W McAllisterC Harker Rhodes
Mar 25, 2011·Attention Deficit and Hyperactivity Disorders·Thomas A SontagKlaus W Lange
Mar 25, 2011·Attention Deficit and Hyperactivity Disorders·Raul R Gainetdinov
Nov 20, 2012·CNS Drugs·David DevosRegis Bordet
Jun 10, 2004·Neurochemistry International·E Sylvester ViziBalazs Lendvai
Aug 6, 1999·Biological Psychiatry·R R GainetdinovM G Caron
Apr 2, 2003·Brain Research. Brain Research Reviews·Eugen DavidsRoss J Baldessarini
Oct 16, 2002·Trends in Pharmacological Sciences·Raul R GainetdinovMarc G Caron
Aug 17, 2001·Trends in Neurosciences·R R GainetdinovM G Caron
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Xilu JiaoShanaz Tejani-Butt
Sep 5, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Everett H EllinwoodTong H Lee
May 2, 2001·Parkinsonism & Related Disorders·R NassR D. Blakely
Oct 1, 2012·Journal of Developmental Origins of Health and Disease·Z Y OngB S Muhlhausler
Sep 14, 2006·Nuclear Medicine Communications·Chin-Bin YehWen-Sheng Huang
Nov 14, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·D DevosL Defebvre
Oct 3, 2002·Annual Review of Pharmacology and Toxicology·Raul R Gainetdinov, Marc G Caron
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·Richard Nass, Randy D Blakely
Sep 11, 2009·Theoretical Biology & Medical Modelling·Janet A BestMichael C Reed
Dec 25, 2012·Disease Models & Mechanisms·Matthew C HavrdaKathryn B Holroyd
Feb 18, 2010·PloS One·Deanna M Navaroli, Haley E Melikian
Aug 22, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nora D VolkowMillard Jayne
Oct 1, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Deanna M NavaroliHaley E Melikian
Jan 1, 2010·Pharmacogenomics and Personalized Medicine·Darko TuricEdmund Sonuga-Barke
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·X ZhuangR Hen
Sep 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·Michel CyrMarc G Caron
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·R R GainetdinovM G Caron
Sep 16, 2011·Parkinson's Disease·Ryuji SakakibaraTomonori Yamanishi
Sep 24, 2008·Revue neurologique·E RozeJ Caboche
Jul 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·Mark J FerrisSara R Jones
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald K B PearcePeter Jenner
Nov 22, 2002·Journal of Neuroscience Research·Michaël RougemontVincent Castagné
Sep 6, 2000·The European Journal of Neuroscience·M Benoit-MarandF Gonon
Jul 25, 2000·Mayo Clinic Proceedings·T D Challman, J J Lipsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.